000			01244nam a2200133 4500
008			250624b |||||||| |||| 00| 0 eng d
100			_aTan Xiaoxia
245			_aClinical observation of the transition from short-term intensive insulin therapy to IDegLira combined with metformin in Chinese patients with type 2 diabetes mellitus
300			_aP 195-200
520			_aThe safety and efficacy of transitioning from short-term intensive insulin therapy to a regimen of insulin degludec/liraglutide (IDegLira) combined with metformin in type 2 diabetes mellitus patients is evaluated in the present study. Conducted at Shenzhen Luohu Hospital Group, the study involved 81 patients who switched from continuous subcutaneous insulin infusion to IDegLira and metformin after four days. Results showed significant improvements: insulin doses decreased from 40.28 to 14.79 IU, HbA1c levels fell from 9.94% to 7.67%, and body weight slightly reduced. The transition also enhanced glycemic control, with reduced mean glucose and variation, and increased time in range.
654			_aIDegLira _ametformin _ashort-term intensive insulin therapy _atype 2 diabetes mellitus
773	0		_0125299 _9112519 _tCurrent Science _x 0011-3891
942			_cJA
999			_c131850 _d131850